Brazil extends R$640m A&E modernisation
This article was originally published in Clinica
Executive Summary
Authorities from Palmas, the capital of Brazil's Tocantins state, have begun negotiations with the federal health ministry on how they will spend their share of a R$640m (US$266m) investment in A&E service modernisation in 2005-06, mainly for equipment. Tocantins thus becomes the tenth of Brazil's 27 states to be involved in the QualiSUS programme to improve A&E facilities and meet stringent new standards of care. It has so far been implemented in five state capitals - Porto Alegre, Recife, Rio de Janeiro, Fortaleza and Aracaju - and is currently being set up in a further four: Belo Horizonte, Goiania, Natal and Curitiba. By the end of this year, the health ministry aims to cover the main A&E specialties in all 27 states (including the Federal District). QualiSUS stands for Qualificacao da Atencao a Saude no SUS (Sistema Unico di Saude).
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.